‘Boiling frog' effect makes people oblivious to threat of climate crisis, shows study
Researchers at Carnegie Mellon University in Pennsylvania wondered if climate change could be made more obvious by presenting it in binary terms. Local newspaper archives describing ice skating on Lake Carnegie when it froze in winter inspired a simple experiment.
Some test subjects were shown temperature graphs of a fictional town's winter conditions; others had a chart showing whether or not a fictional lake froze each year. The result, published in Nature, showed those who receiving the second graphic consistently saw climate change as more real and imminent.
Binary data gives a clearer impression of the 'before' and 'after'. The disappearing ice is more vivid and dramatic than a temperature trace, even though the underlying data is the same.
'We are literally showing them the same trend, just in different formats,' says Rachit Dubey, a co-author of the study.
These results should help drive more effective ways of communicating the impact of climate change in future by finding simple binary, black-and-white examples of its effects.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
an hour ago
- The Sun
Horrifying ancient meal loved by Neanderthals is a dieter's dream – but would YOU eat sickening dish?
NEANDERTHALS may have feasted on maggot-infested meat as a core part of their diet, according to a new study. But the pungent delicacy was more than simply "starvation rations", said Melanie Beasley, assistant professor of anthropology at Purdue University, Indiana. 2 A number of Indigenous communities have viewed putrefied - or fermented - meat as highly desirable. It is easier to digest, meaning the body can better and more quickly absorb nutrients without cooking. Experts have long known that Neanderthals - our extinct human ancestor - were omnivores, eating meat and vegetables like most modern people. But chemical signatures found in Neanderthal remains suggest they ate as much meat as lions. Analysis of their bones found too much nitrogen than what a classic omnivore would have. But hominins simply cannot tolerate eating the high levels of protein that large predators can. When humans eat as much protein as Earth's apex predators – or hypercarnivores – over long periods of time, without consuming enough other nutrients they can develop protein poisoning. Also known as "rabbit starvation", protein poisoning can lead to malnutrition and death. Research from Beasley and her team suggests that Neanderthals had a hidden delicacy: maggots. Similar to the historical diets of some indigenous communities, Neanderthals too may have dined on decaying meat. Stunningly lifelike face of 75,000-year-old Neanderthal woman in her 40s recreated after 'best-preserved' skull found It is this that would have boosted their internal nitrogen levels to hypercarnivore-levels, according to the study. Maggots, which are fly larvae, can be a fat-rich source of food. They are unavoidable after you kill another animal, easily collectible in large numbers and nutritionally beneficial. Melanie Beasley, assistant professor of anthropology at Purdue University, Indiana "We suspected that maggots could have been a different potential source of enriched nitrogen-15 in the Neanderthal diet," Beasley explained in a recent article published in The Conversation. "Maggots, which are fly larvae, can be a fat-rich source of food. "They are unavoidable after you kill another animal, easily collectible in large numbers and nutritionally beneficial." Beasley and her colleagues used data from a forensic anthropology project focused on how nitrogen might help estimate time since death to investigate the possibility. "I had originally collected modern muscle tissue samples and associated maggots at the Forensic Anthropology Center at University of Tennessee, Knoxville, to understand how nitrogen values change during decomposition after death," she said. "While the data can assist modern forensic death investigations, in our current study we repurposed it to test a very different hypothesis. "We found that stable nitrogen isotope values increase modestly as muscle tissue decomposes, ranging from -0.6 permil to 7.7 permil." The researchers found that maggots found in dried, frozen or cached animal foods would have inflated the nitrogen levels in ancient humans during the Late Pleistocene era. Research shows that [nitrogen-15] values are higher for cooked foods, putrid muscle tissue from terrestrial and aquatic species, and, with our study, for fly larvae feeding on decaying tissue. "Neanderthals' cultural practices, similar to those of Indigenous peoples, might be the answer to the mystery of their high [nitrogen-15] values. "Ancient hominins were butchering, storing, preserving, cooking and cultivating a variety of items. "All these practices enriched their paleo menu with foods in forms that nonhominin carnivores do not consume. "Research shows that [nitrogen-15] values are higher for cooked foods, putrid muscle tissue from terrestrial and aquatic species, and, with our study, for fly larvae feeding on decaying tissue." Although maggots may not solely explain the lion-like nitrogen levels in Neanderthals, according to the researchers. It is still unclear how many maggots an ancient human would need to eat to account for so much nitrogen. More research is needed on changes in nitrogen-15 values of foods processed, stored and cooked following Indigenous traditional practices to "help us better understand the dietary practices of our ancient relatives," said Beasley. 2
Reuters
an hour ago
- Reuters
Celcuity's triple cancer drug combo tops AstraZeneca's in cutting progression in study
July 28 (Reuters) - Celcuity (CELC.O), opens new tab said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer, sending the biotech firm's shares surging more than twofold in premarket trading. The drug, gedatolisib, in combination with Pfizer's (PFE.N), opens new tab Ibrance and AstraZeneca's (AZN.L), opens new tab endocrine therapy Faslodex, reduced the risk of disease progression or death by 76%, compared to Faslodex alone in previously treated HR+/HER2- advanced breast cancer patients in a late-stage study. HR+/HER2- breast cancer accounts for about 70% of all breast cancers. The combination treatment helped patients live for an average of 9.3 months without progression of the disease, compared to about two months with Faslodex. Gedatolisib belongs to a class of drugs called PAM inhibitors, which include Novartis' (NOVN.S), opens new tab Afinitor and AstraZeneca's Truqap. The treatment was better tolerated in the late-stage trial than a previous early-stage study, with lower rates of high blood sugar and inflammation in the tissue lining the mouth, Celcuity said, without offering further details. The study also showed that a double combination of gedatolisib and Ibrance reduced the risk of disease progression or death by 67%, compared to Faslodex. This combination increased survival without progression of the disease in patients by 7.4 months on average, compared to about two months with Faslodex. Celcuity plans to report full results from this late-stage study and data from a separate trial in patients whose tumors had alterations in some genes later this year. It expects to apply for U.S. marketing approval in the fourth quarter. Shares of the Minnesota-based firm jumped nearly 114% to $29.4 before the bell.
Reuters
16 hours ago
- Reuters
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.
